Detalles de la búsqueda
1.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Oncologist
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630540
2.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573926
3.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
; 27(3): e286-e293, 2022 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35274718
4.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971318
5.
Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 122(3): 411-9, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26540173
6.
A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer.
Prostate
; 74(15): 1544-50, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25175831
7.
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290965
8.
CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
Clin Genitourin Cancer
; 21(1): 106.e1-106.e8, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945133
9.
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(1): 109-116, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707357
10.
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914579
11.
Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity.
Curr Oncol
; 29(4): 2530-2538, 2022 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35448181
12.
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
JAMA Netw Open
; 5(6): e2216379, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687336
13.
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.
Curr Oncol
; 28(2): 1518-1527, 2021 04 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33924380
14.
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer.
JCO Clin Cancer Inform
; 5: 912-920, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34464153
15.
An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
JAMA Oncol
; 7(3): 379-385, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507236
16.
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study.
Clin Genitourin Cancer
; 19(4): 354-361, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33863648
17.
Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors.
Eur Urol Oncol
; 4(1): 102-111, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786162
18.
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.
J Geriatr Oncol
; 12(5): 820-826, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33674246
19.
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival.
JAMA Netw Open
; 4(1): e2021869, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33475752
20.
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer Med
; 10(4): 1212-1221, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33463028